Air (17/07/2026)

In a radio interview, Engineering News editor Martin Creamer says DRDGOLD will spend about R10 billion on five gold-from-waste projects, including sites at Ergo and on the Far West Rand. He also cites Sibanye-Stillwater’s R964 million capital plan for the K4 platinum group metals shaft at Marikana, adding 48 years of mine life. Mintek is also highlighted for expanded mineral research.

Original reporting
Published Jul 17, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 1:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Air (17/07/2026) — source image
Decision brief

The 30-second read

$DRDBullishLow
01

Why it matters

Disclosed capex figures for DRDGOLD’s gold-from-waste projects and Sibanye-Stillwater’s K4 shaft provide incremental fundamental detail, but without financial targets or execution milestones that would typically drive immediate repricing.

02

Market read

For traders, the actionable signal is the scale and direction of capex and mine-life extension, but the lack of production and financial metrics limits near-term trading usefulness.

03

What to watch

The transcript omits key trading drivers such as expected production volumes, capex phasing, IRR/NPV, funding structure, and regulatory or technical risks for the specific projects.

Relevance 5/10Novelty 4/10Timing: radio transcript published July 17, 2026

Background

The piece is a transcript from SAfm’s “At the Coalface” featuring Engineering News editor Martin Creamer discussing South African mining investment and research priorities.

Company-level read

Ticker impact

$DRDBullishMedium confidence
Context

Article says DRDGOLD will spend R10-billion on five new gold-from-waste projects, expanding retreatment and environmental restoration plans.

Expected impact

Mild positive bias for sentiment, with limited near-term trading edge without incremental earnings or cost/production targets.

Evidence & confidence

The article discloses a large capex figure and project focus, which can matter for expectations, but lacks quantified production, margins, or schedule details that typically drive sharper repricing.

$SBSWBullishMedium confidence
Context

Article states Sibanye-Stillwater will spend about R964-million on the K4 shaft at Marikana, adding 48 years of mine life.

Expected impact

Moderately positive for longer-horizon valuation, with near-term impact likely muted absent updated production/cost guidance.

Evidence & confidence

A specific multi-year capex and mine-life extension are concrete, but the article does not provide expected output, capex phasing, or PGM price assumptions.

Market effects

Reinforces a sector theme of retreatment (gold) and life-of-mine extensions (PGMs) in South Africa, potentially supporting investor confidence in resource longevity.

Highlights East Rand and Far West Rand gold retreatment and Marikana (Rustenburg municipal area) PGM development, relevant to local employment and permitting sentiment.

Limited direct global read-across because the article provides no export, offtake, or global demand/pricing updates.

Counterpoint

Large capex announcements can be value-destructive if execution, permitting, or unit costs rise, especially when commodity price uncertainty is emphasized.

Key entities

  • DRDGOLD

    Spending R10-billion on five new gold-from-waste projects to extract gold from mine dumps and tailings while restoring the environment.

  • Sibanye-Stillwater

    Spending about R964-million over two years on the K4 shaft at Marikana, adding 48 years of mine life.

  • Mintek

    Targets greater global recognition for mineral research, with emphasis on platinum group metals research capacity in South Africa.

Related articles

$DRDMed

Red tape blurs DRDGold’s Vision 2028

DRDGold said it is awaiting multiple permits, including two water use licences and government approval for “beneficial occupation” of the RTSF tailings dam, before completing its Vision 2028 R10bn expansion. The plan targets 25% higher annual gold output to 200,000 oz. Analysts at HC Wainwright and Hannam & Partners cite execution and permit delays; Hannam cut its target to R76 from R79.

$BKRMed

Baker Hughes extends long-term service deal for Nigeria LNG Train 7

Baker Hughes said it won a 13-year lifecycle services deal with Nigeria LNG for turbomachinery at NLNG’s Train 7 expansion on Bonny Island. The scope covers heavy-duty gas turbines, centrifugal compressors, remote monitoring via Baker Hughes’ digital platform, and local support. Train 7 is expected to raise capacity from 22 to 30 MMtpa.

$BKRMed

Baker Hughes wins subsea systems contract for Angola's Greater PAJ field

Baker Hughes said it won a contract from Azule Energy to supply subsea production systems for the Greater PAJ ultra-deepwater project offshore Angola. Scope includes horizontal subsea trees, control modules, workover control systems and related equipment plus installation and support. Greater PAJ is expected to start producing in 2029 via an FPSO processing up to 95,000 bpd, with deliveries starting in 2027.

$WENMed

57-year-old Burger chain closed 28 restaurants, 100s more coming

Wendy’s (WEN) said it closed 28 restaurants and expects to close 5% to 6% of U.S. units (about 289 to 358) in 1H 2026, with possible additional selective closures. The company reported 2Q FY2026 systemwide sales down 6.5% YoY, U.S. systemwide down 8.2%, and U.S. same-restaurant sales down 7%. Wendy’s launched a turnaround plan and withdrew its 2026 outlook.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.